Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows (Unaudited)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Statement of Cash Flows [Abstract]      
Restricted Cash $ 1,413 $ 1,413 $ 3,134
Net income (loss) 16,602 41,682 113,167
Operating Activities:      
Depreciation and amortization 16,154 45,530 38,405
Equity (income) loss from equity method investments 59 (163) 301
Non-cash debt and financing costs   3,013 1,085
(Gain) loss on derivative instruments designated as hedges   0 (15,988)
Stock-based compensation expense   9,258 10,011
(Gain) loss on write down and disposal of long-lived assets 1,076 2,095 1,611
Pension and other post-retirement benefits   4,009 3,823
Change in deferred income taxes   13,430 1,395
Change in operating assets   (7,697) (42,130)
Change in operating liabilities   (20,327) (61,485)
Other   (95) 556
Net Cash Provided by (Used in) Operating Activities   90,735 82,727
Investing activities:      
Capital expenditures   (104,129) (77,650)
Proceeds from Sale of Productive Assets   0 169
Acquisitions, net of cash received   (1,294) 0
Proceeds from Equity Method Investment, Distribution   433 776
Payments to Acquire Interest in Joint Venture   (5,000) (2,000)
Payments for (Proceeds from) Hedge, Investing Activities   4,536 0
Net Cash Provided by (Used in) Investing Activities   (105,454) (78,705)
Financing activities:      
Proceeds from Issuance of Secured Debt   0 283,853
Proceeds from Issuance of Unsecured Debt   31,611 9,495
Proceeds from Hedge, Financing Activities   6,476 0
Payment for Debt Extinguishment or Debt Prepayment Cost   0 (3,234)
Payments of Debt Issuance Costs   0 (1,797)
Payments for (Proceeds from) Hedge, Financing Activities   (2,839) 0
Finance Lease, Principal Payments (407) (1,153) 0
Payments of long-term debt   (13,149) (332,063)
Proceeds from exercise of stock options   298 480
Payments of Ordinary Dividends, Common Stock 0 (5,803) (2,873)
Net Cash Provided by (Used in) Financing Activities   15,441 (46,139)
Net increase (decrease) in cash, cash equivalents and restricted cash   722 (42,117)
Effect of foreign currency fluctuations on cash, cash equivalents and restricted cash   1,221 (7,236)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 209,861 209,861 237,493
Cash, cash equivalents, and restricted cash, at end of fiscal period $ 208,448 $ 208,448 $ 234,359